Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome

Nephrology

Volumn 12, Issue 4, 2007, Pages 386-390

  Davenport, Andrew ^a   Stearns, Michael P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Dialysis; Hypocalcaemia; Pamidronate; Parathyroidectomy

Indexed keywords

ALFACALCIDOL; CALCIUM; PAMIDRONIC ACID;

ADULT; BONE DENSITY; BONE REMODELING; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIALYSIS; FEMALE; HOSPITALIZATION; HUMAN; HUNGRY BONE SYNDROME; HYPOCALCEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; HYPOCALCEMIA; MALE; MIDDLE AGED; PARATHYROIDECTOMY; SYNDROME; TIME FACTORS;

EID: 34447534214     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00806.x     Document Type: Review

References (17)

1. McHenry CR, Wilhelm SM, Ricanati E. Refractory renal hyperparathyroidism: Clinical features and outcome of surgery. Am. Surg. 2001 67 : 310 16.
2. Jofre R, Gomez JML, Menarguez J et al. Parathyroidectomy: Whom and when? Kid Int. 2003 63 (Suppl. 85 S97 S100.
3. Zahiri K, Hachim K, Fathi el M, Benghanem MG, Ramdani B, Zaid B. Calcium needs in haemodialyzed parathyroidectomized patients. Ann. Med. Interne (Paris) 2002 153 : 433 9.
4. Strickland PL, Recabaren J. Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of post operative hypocalcaemia? Am. Surg. 2002 68 : 1080 82.
5. Koonsman M, Hughes K, Dickerman R, Brinker K, Dunn E. Parathyroidectomy in chronic renal failure. Am. J. Surg. 1994 168 : 631 5.
6. Rogers MJ. New insights into the molecular mechanisms of action of biphosphonates. Curr. Pharm. Des 2003 9 : 2643 58.
7. Coco M, Glicklich D, Faugere MC et al. Prevention of bone loss in renal transplant recipients: A prospective randomised trial of intravenous pamidronate. J. Am. Soc. Nephrol. 2003 10 : 2669 76.
8. Torregrosa JV, Moreno A, Mas M, Ybarra J, Fuster D. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing haemodialysis. Kid Int. 2003 63 (Suppl. 85 S88 S90.
9. Cozzolino M, Gallieni M, Corsi C, Bastagli A, Brancaccio D. Management of calcium refilling post-parathyroidectomy in end stage renal disease. J. Nephrol. 2004 17 : 3 8.
10. Kumar A, Ralston SH. Biposphonates prevent the hungry bone syndrome. Nephron 1966 74 : 729.
11. Lee IT, Sheu WHH, Tu ST, Kuo SW, Pei D. Biphosphonate pre-treatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J. Bone Miner Metab 2006 24 : 255 8.
12. Davenport A, Goel S, Mackenzie C. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure. Scand. J. Nephrol. Urol. 1993 27 : 447 51.
13. Walsh JP. Paget's disease of bone. Med. J. Aust. 2004 181 : 262 5.
14. Haverbeke G, Pertile G, Claes C, Zeyen T. Posterior uveitis: An under-recognized adverse effect of pamidronate: 2 case reports. Bull. Soc. Belge Ophthalmol. 2003 290 : 71 6.
15. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J. Oral Maxillofac Surg. 2003 61 : 1115 17.
16. Torregrosa JV, Moreno A, Mas M, Ybarra J, Fuster D. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int. Suppl 2003 85 : S88 90.
17. Saha H, Ala-Houhala I, Ylitalo P, Kleimola T, Pasternack A. Skeletal deposition of clodronate is related to parathyroid function and bone turnover in dialysis patients. Clin. Nephrol. 2002 58 : 47 53.